A

NYSE

AGILENT TECHNOLOGIES, INC.

Health Care, Life Sciences Tools & Services

$145.97

close 7 Aug 2026

+27.90%

52-week change

$41.20B

market cap

$108.35

$160.27

52-week range

Valuation

Market cap$41.20B

P/E (TTM / 5y avg)29.31x31.50x

Forward P/E (FY2026 / FY2027)24.09x22.08x

PEG (TTM / fwd)9.712.65

P/S (TTM)5.70x

P/B5.78x

EV/EBITDA (TTM)23.36x

FCF yield (TTM)2.64%

Cash flow & dividend

FCF (TTM)$1.09B

FCF per share (TTM)$3.85

FCF margin (TTM)15.03%

Dividend yield (indicated / 5y avg)0.70%0.70%

Annualized dividend$1.02

Payout ratio (EPS / FCF)20.16%26.22%

Growth & quality

Revenue YoY, latest Q+10.01%

Diluted EPS YoY, latest Q+60.00%

Operating margin (TTM)21.50%

Net margin (TTM)19.55%

ROE (latest FY)19.33%

Net debt / EBITDA (TTM)0.85

Interest coverage (TTM)14.81

Price

-8.33%-1.73%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +5.41%10Y CAGR +5.58%

Diluted EPS

5Y CAGR +14.72%10Y CAGR +14.31%

FCF per share

5Y CAGR +9.51%10Y CAGR +12.55%

Operating cash flow

5Y CAGR +11.10%10Y CAGR +11.78%

Free cash flow

5Y CAGR +7.51%10Y CAGR +10.78%

Dividends per share

5Y CAGR +6.85%10Y CAGR +9.53%

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -1.55%10Y CAGR -1.65%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date25 Aug 2026amc

EPS estimate$1.52

Revenue estimate$1.88B

Last reported

Date—

EPS——

Revenue——